APCCC 2019 Conference Coverage

Viewing 1-20 of 58 articles

APCCC 2019: Local Treatment of The Primary (Surgery) in the Metastatic Situation

APCCC 2019: PARP Inhibition for Metastatic Castration-Resistant Prostate Cancer

APCCC 2019: Management of Hot Flushes

APCCC 2019: Which Systemic Therapy for Which Patients with Newly Diagnosed Metastatic Prostate Cancer?

APCCC 2019: Wishes in Locally Advanced Prostate Cancer

APCCC 2019: PSMA Targeted Therapies

APCCC 2019: Wishes in Biomarkers

APCCC 2019: Wishes in Polymetastatic Prostate Cancer

APCCC 2019: Wishes in Oligometastatic Prostate Cancer

APCCC 2019: Wishes in Prostate Cancer Imaging

APCCC 2019: Wishes in Global Access to Treatments

APCCC 2019: Synthesis - Optimal Treatment of Men with Newly Diagnosed Prostate Cancer

APCCC 2019: Immunotherapy for Metastatic Castrate Resistant Prostate Cancer

APCCC 2019: Radium-223 and Bone Health Agents: Lessons Learned

APCCC 2019: Optimal Steroid Use with Abiraterone

APCCC 2019: Management of Fatigue, Cognition, Dementia

APCCC 2019: Management of Metabolic Changes

APCCC 2019: Management of Sexuality and Incontinence Issues in Advanced Prostate Cancer

APCCC 2019: Debate: Antiresorptive Therapy to Reduce SRE Risk in Men with Bone-mCRPC -- For Select Men with CRPC and Bone Metastases

APCCC 2019: Testosterone Measurement - Which Test and When?

1
2
3